Skip to main content

RA BRIDGE and RA BRANCH trials: Baricitinib and VTE Risk

Jun 07, 2026 9:41 am

Drs. Mrinalini Dey and Jon Giles discuss abstract LB0009 presented at EULAR 2026 in London
 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×